MARC ayrıntıları
| 000 -LEADER |
| fixed length control field |
01782nam a2200289 i 4500 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
| fixed length control field |
150126s2003 njum b a001 0 eng d |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
| LC control number |
2003045085 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
0470843268 |
| Qualifying information |
cloth : alk. paper |
|
| International Standard Book Number |
0470843276 |
| Qualifying information |
pbk. : alk. paper |
| 040 ## - CATALOGING SOURCE |
| Original cataloging agency |
DLC |
| Transcribing agency |
DLC |
| Modifying agency |
C#P |
| -- |
OSU |
| -- |
BAUN |
| Language of cataloging |
eng |
| Description conventions |
rda |
| 049 ## - LOCAL HOLDINGS (OCLC) |
| Holding library |
BAUN_MERKEZ |
| 050 00 - LIBRARY OF CONGRESS CALL NUMBER |
| Classification number |
RS380 |
| Item number |
.W34 2003 |
| 060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
| Classification number |
QV778 |
| Item number |
W224 2003 |
| 082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
| Edition number |
21 |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
| Personal name |
Walsh, Gary |
| Titles and other words associated with a name |
(Biochemist) |
| 245 10 - TITLE STATEMENT |
| Title |
Biopharmaceuticals : |
| Remainder of title |
biochemistry and biotechnology / |
| Statement of responsibility, etc |
Gary Walsh. |
| 250 ## - EDITION STATEMENT |
| Edition statement |
2nd edition |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
| Place of production, publication, distribution, manufacture |
Hoboken, NJ : |
| Name of producer, publisher, distributor, manufacturer |
John Wiley, |
| Date of production, publication, distribution, manufacture, or copyright notice |
c2003. |
| 300 ## - PHYSICAL DESCRIPTION |
| Extent |
xviii, 551 pages : |
| Other physical details |
illustrations ; |
| Dimensions |
26 cm. |
| 336 ## - CONTENT TYPE |
| Content Type Term |
text |
| Content Type Code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
| Media Type Term |
unmediated |
| Media Type Code |
unmediated |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
| Carrier Type Term |
volume |
| Carrier Type Code |
volume |
| Source |
rdacarrier |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 00 - FORMATTED CONTENTS NOTE |
| Title |
-- Contents |
| -- |
Preface |
| -- |
Ch. 1 Pharmaceuticals, biologics and biopharmaceuticals |
| -- |
Ch. 2 The drug development process |
| -- |
Ch. 3 The drug manufacturing process |
| -- |
Ch. 4 The cyotkines - the interferon family |
| -- |
Ch. 5 Cytokines: interleukins and tumour necrosis factor |
| -- |
Ch. 6 Haemopoietic growth factors |
| -- |
Ch. 7 Growth factors |
| -- |
Ch. 8 Hormones of therapeutic interest |
| -- |
Ch. 9 Blood products and therapeutic enzymes |
| -- |
Ch. 10 Antibodies, vaccines and adjuvants |
| -- |
Ch. 11 Nucleic acid therapeutics |
| -- |
App. 1 Biopharmaceuticals thus far approved in the USA or European Union |
| -- |
App. 2 Some Internet addresses relevant to the biopharmaceutical sector |
| -- |
App. 3 Two selected monographs reproduced from the European Pharmacopoeia (Products of recombinant DNA technology; Interferon a-2 concentrated solution) |
| -- |
App. 4 Manufacture of biological medicinal products for human use |
| -- |
Index |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Pharmaceutical biotechnology. |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
| Source of classification or shelving scheme |
Library of Congress Classification |
| Koha item type |
Kitap |